anti-Lung Carcinoma antibody [CHALU2]

Arigo Biolaboratories

anti-Lung Carcinoma antibody [CHALU2]

23

Flow Cytometry, ImmunoFluorescence, ImmunoCytoChemistry

Research Use Only

Monoclonal

CHALU2

1 mg/ml

Unconjugated

Mouse

IgG1

Cancers that derived from epithelium of the lung are called lung carcinoma. Each year, lung carcinoma causes over one million of deaths worldwide. Based on the size of cancer cells, lung carcinoma is grouped into two types: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). SCLC is strongly associated with smokers. SCLC grows and metastases very fast and responds to surgical resection poorly. NSCLS includes squamous cell carcinoma, adenocarcinoma and large cell carcinoma. Antibodies against lung carcinoma can be used as a guiding tool in bio-missile cancer therapy strategy.

Human

-20°C

12352203